Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Next NR is the PP!
View:
Post by Enzolini on Jun 07, 2020 7:41pm

Next NR is the PP!

Classic Kalytera they send out a few NR that are somewhat positive then they come out with another PP for Salzman! Nothing has changed here over two years of making payments to Salzman. And yes some of you are going to say I'm a basher unfortunately I have more shares in this company then all you people on this board! I really thought something was going to happen with the GVHD program but I guess I was wrong. I keep hoping something positive will happen with this company! And call penny by his name George the Greek loser!!
Comment by BrianCano444 on Jun 07, 2020 7:51pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Jun 07, 2020 10:44pm
Acquisition should be contingent on Salzman receiving BARDA funding for COVID. Salzman has had Robert Farrell by the balls for too long. Surprised Farrell hasn't resigned out of shame.  Speaking of GvHD, hard to believe a trial involving 50 patients (with only 25 receiving CBD) for 100 days would cost $10mm?
Comment by BrianCano444 on Jun 07, 2020 10:53pm
This post has been removed in accordance with Community Policy
Comment by Raiders11 on Jun 08, 2020 9:52am
Know doubt expensive,scientists making a fortune on the backs of shareholders.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities